The US Trade Representative’s Office says it will exclude 12 medtech products from a long list of items imported from China that are slated to be slapped with a 25% tariff.
The 9 July decision from the USTR comes on the heels of testimony by device industry advocacy group AdvaMed in late June pleading with the trade office to remove a host of medtech equipment and supplies from the tariff list. While the list does not exclude all products on AdvaMed’s “wish list” of items it hoped could escape the tariffs, it does include some of them
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?